Lv1
18 积分 2024-01-10 加入
Real-World Chinese Study of the Effectiveness and Safety of Switching From Dupilumab to Stapokibart in Patients With Moderate-to-Severe Atopic Dermatitis
2个月前
已完结
Guidelines for the treatment of psoriasis with biologics and small-molecule drugs in China （2024）
3个月前
已完结
[Guidelines for the prevention and management of bronchial asthma (2024 edition)]
3个月前
已完结
Efficacy and safety analysis of Dupilumab for atopic dermatitis of all ages in Chinese population: Real‐world data from a single center
3个月前
已完结
59618 Lebrikizumab improves itch, itch interference on sleep and skin pain in patients with moderate-to-severe atopic dermatitis previously treated with dupilumab
3个月前
已关闭
Increasing dosing intervals for biologics in atopic dermatitis-why, who, when and how?
3个月前
已完结
Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice
3个月前
已完结
Use of Extended Dosing Intervals of Dupilumab in Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
3个月前
已完结
Use of Extended Dosing Intervals of Dupilumab in Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
3个月前
已关闭
Use of Extended Dosing Intervals of Dupilumab in Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
3个月前
已关闭
皖公网安备34019202002308
